.Regeneron is back along with lasting follow-up for its own LAG-3 prevention and also PD-1 preventio...
.AstraZeneca has shared an early look at the efficiency of its internal antibody-drug conjugate (ADC...
.After announcing a stage 3 launch based upon beneficial midstage results, iTeos as well as GSK are ...
.The FDA must be more open and also joint to release a surge in approvals of unusual illness medicat...
.It is actually an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 trial, yet the biote...
.Neurocrine Biosciences' schizophrenia course pivot has stopped working. The biotech was not able to...
.Sanofi has actually brought in an overdue entry to the radioligand party, spending 100 million euro...
.After F2G's initial try to receive a brand-new training class of antifungal to market was actually ...
.Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to retract the finan...